US Stock MarketDetailed Quotes
CDT Conduit Pharmaceuticals
- 0.104
- -0.004-3.61%
Close Nov 22 16:00 ET
- 0.100
- -0.004-3.85%
Post 19:59 ET
10.70MMarket Cap-495P/E (TTM)
0.108High0.097Low24.85MVolume0.108Open0.108Pre Close2.53MTurnover42.52%Turnover RatioLossP/E (Static)102.85MShares7.83052wk High-1.17P/B6.08MFloat Cap0.07952wk Low--Dividend TTM58.44MShs Float25.000Historical High--Div YieldTTM10.10%Amplitude0.079Historical Low0.101Avg Price1Lot Size
About Conduit Pharmaceuticals Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
Company Profile
SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEOMr. David Tapolczay
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4581 Tamiami Trail North,Suite 200
CityNaples
ProvinceFlorida
CountryUnited States of America
Zip Code34103
Phone1-646-491-9132
Websitehttp://www.conduitpharma.com
Company Executives
- Name
- Position
- Salary
- David Tapolczay
- Chief Executive Officer and Director
- 1.34M
- James Bligh
- Director, Senior Vice President, Strategy and Interim Chief Financial Officer
- --
- Dr. Freda C. Lewis-Hall,M.D.
- Chairman of the Board
- 275.31K
- Simon Fry
- Director
- --
- Dr. Andrew James Regan
- Director
- 842.08K
- Faith L. Charles
- Independent Director
- 267.43K
- Chele Chiavacci Farley
- Independent Director
- 268.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data